767 related articles for article (PubMed ID: 21624500)
21. Drug hepatotoxicity from a regulatory perspective.
Senior JR
Clin Liver Dis; 2007 Aug; 11(3):507-24, vi. PubMed ID: 17723917
[TBL] [Abstract][Full Text] [Related]
22. A modified multiparametric assay using HepaRG cells for predicting the degree of drug-induced liver injury risk.
Tomida T; Okamura H; Yokoi T; Konno Y
J Appl Toxicol; 2017 Mar; 37(3):382-390. PubMed ID: 27480533
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of DILI Predictive Hypotheses in Early Drug Development.
Chan R; Benet LZ
Chem Res Toxicol; 2017 Apr; 30(4):1017-1029. PubMed ID: 28257576
[TBL] [Abstract][Full Text] [Related]
24. Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges.
Senior JR
Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S9-17. PubMed ID: 25352324
[TBL] [Abstract][Full Text] [Related]
25. Development of binary classification models for assessment of drug-induced liver injury in humans using a large set of FDA-approved drugs.
Zhang H; Zhang HR; Hu ML; Qi HZ
J Pharmacol Toxicol Methods; 2022; 116():107185. PubMed ID: 35623583
[TBL] [Abstract][Full Text] [Related]
26. Causality assessment for suspected DILI during clinical phases of drug development.
Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
[TBL] [Abstract][Full Text] [Related]
27. Review article: drug-induced liver injury in clinical practice.
Björnsson E
Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
[TBL] [Abstract][Full Text] [Related]
28. Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.
Zhu X; Kruhlak NL
Toxicology; 2014 Jul; 321():62-72. PubMed ID: 24721472
[TBL] [Abstract][Full Text] [Related]
29. Predicting drug-induced liver injury in human with Naïve Bayes classifier approach.
Zhang H; Ding L; Zou Y; Hu SQ; Huang HG; Kong WB; Zhang J
J Comput Aided Mol Des; 2016 Oct; 30(10):889-898. PubMed ID: 27640149
[TBL] [Abstract][Full Text] [Related]
30. Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury.
McEuen K; Borlak J; Tong W; Chen M
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640208
[TBL] [Abstract][Full Text] [Related]
31. Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
Minerali E; Foil DH; Zorn KM; Lane TR; Ekins S
Mol Pharm; 2020 Jul; 17(7):2628-2637. PubMed ID: 32422053
[TBL] [Abstract][Full Text] [Related]
32. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
[TBL] [Abstract][Full Text] [Related]
33. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
34. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Liu Z; Shi Q; Ding D; Kelly R; Fang H; Tong W
PLoS Comput Biol; 2011 Dec; 7(12):e1002310. PubMed ID: 22194678
[TBL] [Abstract][Full Text] [Related]
35. Needles in haystacks.
Reuben A
Am J Gastroenterol; 2007 Nov; 102(11):2444-6. PubMed ID: 17958757
[TBL] [Abstract][Full Text] [Related]
36. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
37. Review article: Drug-induced liver injury--its pathophysiology and evolving diagnostic tools.
Au JS; Navarro VJ; Rossi S
Aliment Pharmacol Ther; 2011 Jul; 34(1):11-20. PubMed ID: 21539586
[TBL] [Abstract][Full Text] [Related]
38. Drug-induced liver injury: what was new in 2013?
Chalhoub WM; Sliman KD; Arumuganathan M; Lewis JH
Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):959-80. PubMed ID: 24746272
[TBL] [Abstract][Full Text] [Related]
39. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
40. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]